JPS60123486A - Fluoroblasticidin s and its preparation - Google Patents

Fluoroblasticidin s and its preparation

Info

Publication number
JPS60123486A
JPS60123486A JP58231248A JP23124883A JPS60123486A JP S60123486 A JPS60123486 A JP S60123486A JP 58231248 A JP58231248 A JP 58231248A JP 23124883 A JP23124883 A JP 23124883A JP S60123486 A JPS60123486 A JP S60123486A
Authority
JP
Japan
Prior art keywords
formula
fluoroblasticidin
culture
antibiotic
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58231248A
Other languages
Japanese (ja)
Inventor
Nozomi Otake
大岳 望
Haruo Seto
治男 瀬戸
Tadayuki Ishiyama
石山 忠之
Masao Kato
正雄 加藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGC Inc
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Priority to JP58231248A priority Critical patent/JPS60123486A/en
Publication of JPS60123486A publication Critical patent/JPS60123486A/en
Pending legal-status Critical Current

Links

Abstract

NEW MATERIAL:Fluoroblasticidin S shown by the formula I or its salts. USE:A fungicide of antibiotic for agriculture, an antibiotic showing improved effect especially on blast of rice plant. PREPARATION:A bacterium belonging to the genus Streptomyces, capable of producing blasticidin S is cultivated in the presence of fluorocytocine shown by the formula II in a culture solution containing a C source, N source, inorganic salt, a very small amount of organic omponents, etc. by shaking culture or by aerated spinner sulture at 20-40 deg.C, to give a compound shown by the formula I . Properties of monoacetate type fluoroblasticidin S. Melting pont: 215-220 deg.C. Molecular formula: C19H29N8O5F. Value of elemental analysis: theoretical value (wt%) C 48.71, H 6.24, N 23.92,) 17.08, measured value (wt%) C 48.52, H 6.30, N 23.43, O 17.21, etc.

Description

【発明の詳細な説明】 不発明は新規抗生物質であるフルオロプラストサイジン
Sまたはその塩類、およびそれらの製法に関するもので
ある。
DETAILED DESCRIPTION OF THE INVENTION The invention relates to a novel antibiotic, fluoroplasticidin S or salts thereof, and a method for producing them.

プラストサイジン日(以下BSという)はストノブトマ
イセス机菌から得られる抗生物質として公知である(特
公昭35−16449号公報参服)。BSまたはその塩
ご百は醋楽用殺菌削として使用はれ、特に稲のイモテ病
に卓@を有する抗生物質として広く知られている。、B
S&’tそれ単独で使用されるのみ乃:らず、多くの場
合有機あるいは無機の酸との塩の形で使用され、たとえ
ばベンジルアミノベンゼンスルホン11(4、ドデシル
ベンゼンスルホンm塩、メタンスルホン酸塩、ラウリル
硫Cψ塩、堪醗慮などがめる3、BETは下記式[’l
Dで表わされる塩基性の抗生物質である。
Plasticidin (hereinafter referred to as BS) is known as an antibiotic obtained from the fungus Stonotomyces (Japanese Patent Publication No. 35-16449). BS or its salt is widely used as a disinfectant and is widely known as an antibiotic that is particularly effective against rice imote disease. , B
It is not only used alone, but is often used in the form of salts with organic or inorganic acids, such as benzylaminobenzenesulfone 11 (4, dodecylbenzenesulfone m salt, methanesulfonic acid). salt, lauryl sulfur Cψ salt, and consideration 3, BET is the following formula ['l
It is a basic antibiotic represented by D.

本発明者はBSの薬効向上、薬効持続、新しい薬理作用
の発揮、あるいけ医薬としての適用の可能性を検討する
ために、BSにフッ素原子を導入することを検討した。
The present inventor investigated the introduction of fluorine atoms into BS in order to improve the medicinal efficacy of BS, maintain its medicinal efficacy, exhibit new pharmacological effects, and examine the possibility of application as a medical drug.

農薬や医薬においてフッ素原子の導入は種々の効果を期
待でする。
The introduction of fluorine atoms in agricultural chemicals and medicines is expected to have various effects.

たとえば、フッ素原子を導入嘔れた化合物は、フッ素原
子のない化合物に比べて酵素による伏射反応を阻害るる
いは抑制し、その結果として微生物や細胞の生育や増殖
を内置あるiは抑制し、また薬理作用を持続δせる。ま
た、フッ素原子り極性が高くその結合位置近傍の生体受
答部の活性を変化させたり、化学的安定性を変化させる
。さらに、フッ素原子の導入による疎水化は化合物の脂
溶性を増大させその薬理作用を増大させることも考えら
れる。これらの効果の発揮を目的としてフッ素化された
BSを!#令することを検利した。BSを直接フッ紫化
剤でフッ素化する方法は種々のフッ累化物が生成したり
BEIの分解や変質の虞れが極めて大きくケIll爬使
用しうる方法で、けない、、また、BSにぼフッ素化合
物を結合させる方法はBS特有の化学的構造を大きく変
化させ、その社理作用を全く変化させる虞れが大きい。
For example, a compound containing a fluorine atom inhibits or suppresses the enzymatic reaction by an enzyme compared to a compound without a fluorine atom, and as a result, inhibits the growth and proliferation of microorganisms and cells. It also prolongs the pharmacological action. In addition, the fluorine atom is highly polar and changes the activity of the biological receptor near the bonding site and changes the chemical stability. Furthermore, it is also considered that hydrophobization by introduction of fluorine atoms increases the fat solubility of the compound and increases its pharmacological action. Fluorinated BS for the purpose of exhibiting these effects! # It was decided that the order would be issued. The method of directly fluorinating BS with a fluorinating agent has the extremely high risk of producing various fluoride compounds and decomposing and deteriorating BEI. The method of bonding fluorine compounds greatly changes the chemical structure peculiar to BS, and there is a great possibility that its physical function will be completely changed.

−さらに、BF3分母分母側鎖に分解し、その一部分フ
ッ素化して再結合させてフッ素原子が導入されたBSを
製造することも考えられるが、上記直接フッ素化による
問題点が残るとともに、再結合が困難であった#)f1
3造工程が極めて複雑化する虞れがある。
-Furthermore, it is also possible to produce BS in which fluorine atoms are introduced by decomposing BF3 into denominator side chains, partially fluorinating them, and recombining them.However, problems with the above-mentioned direct fluorination remain, and the recombination was difficult #) f1
There is a risk that the 3-build process will become extremely complicated.

本発明者はBSへのフッ素原子の導入を検討した結果、
フルオロシトシンを前駆体としてBS生産菌を培養し、
その培養物からフッ素原子が導入されたBSを採堆しう
ろことを見い田した。前記式〔…〕で示されるように、
BSはシトシン残基を有している。、従って、フルオロ
シトクンを前駆体として3日生産菌を培養すると、BS
生産菌はフルオロシトクンを取シ込み、7ト77残基が
フルオロ7トシン残基にf%されたBSを生産するもの
と考えられる。勿論、BSS生産上前駆体を必快とする
ことなくBSを生産することができるので、通常フッ素
原子が導入されたBSはBSと併産ちれ、フッ素原子が
導入されたBeは多くの場合B8との混合物から分離し
て得られる。フルオロ7トシンは下記式[111〕で表
わされる公知の化合物であり、抗真菌性医薬として使用
されている。
As a result of examining the introduction of fluorine atoms into BS, the present inventor found that
Cultivating BS-producing bacteria using fluorocytosine as a precursor,
From the culture, they collected BS containing fluorine atoms and found scales. As shown in the above formula [...],
BS has a cytosine residue. Therefore, when culturing 3-day production bacteria using fluorocytocone as a precursor, BS
It is thought that the producing bacteria take in fluorocytocone and produce BS in which the 7-77 residues are converted to fluoro-7 tosine residues. Of course, BS can be produced without requiring a precursor for BSS production, so BS with fluorine atoms introduced is usually co-produced with BS, and Be with fluorine atoms introduced is often co-produced with BS. It is obtained by separating it from a mixture with B8. Fluoro-7tocin is a known compound represented by the following formula [111], and is used as an antifungal drug.

しかし、放税菌を代表とするB8生産菌に対する影智は
ほとんどなく、フルオロシトクンを前駆体としてBS生
産diを培養することができる、。
However, there is almost no knowledge of B8-producing bacteria, such as Lactobacilli, and it is possible to culture BS-producing bacteria using fluorocytokone as a precursor.

不発明は上記方法によって得られるフルオロプラストサ
イジンSまたはその塩類、およびそれらの製法fI:要
旨とするものであり、即ち、下記式〔目で表わされるフ
ルオロプラストサイジンSまたはその塩釘1、 および、フルオロシトクン存在下にプラストサイジンS
生産画分培養し、その培妙物から上記式[1]で表わさ
れるフルオロプラストサイジンSまたはそのiA類を探
をすることt特偵とするフルオロプラストサイジンSま
たはその塩類の製法、でちる。
The non-invention is fluoroplasticidin S or its salts obtained by the above-mentioned method, and their production method fI. and plasticidin S in the presence of fluorocytocone.
A method for producing fluoroplasticidin S or its salts, which involves culturing the produced fraction and searching for fluoroplasticidin S represented by the above formula [1] or its iA group from the cultured product. Chiru.

本発明のフルオロプラストサイジンs(以’−FFBS
という)はフルオロシトクン萌♂す51体の存在下公知
のB8生産園によって生産さnる。、E’19生蟻繭と
しては、前記公報に記!l+!されたストンブトマイセ
ス・グリセオクロモゲニス(S。
Fluoroplasticidin s (hereinafter referred to as '-FFBS) of the present invention
) is produced by a known B8 production farm in the presence of 51 Fluorocytokun moe males. , E'19 live ant cocoon is described in the above bulletin! l+! Stombutomyces griseochromogenis (S.

griseoahromogeneB)などのストンブ
トマイセス稿に鵡するBS生産菌株を使用しうる。また
これらの菌株を檜々の変異処理法によって得た変異菌株
を使用し工、FBSあるいはBSの生産性を高めること
も可能である。
BS-producing strains commonly found in Stombutomyces can be used, such as Griseoahromogene B). Furthermore, it is also possible to increase the productivity of FBS or BS by using mutant strains obtained by mutating these strains.

PBSは、通常の放痔菌類の培養方法に従ってフルオロ
シトクン存在下にBS生産菌を培養し、その培養物から
FBBとBeの混合物をまず分離採取し、次いでその混
合物からFBBとBStl−分離することによって得ら
れる。たとえば、フルオロシトシンと通常放線鉋の培養
に使用される炭素源、窒素源、無機塩類、有機微枇成分
などを有する培養液中で振盪あるいは通気借拌下約20
〜40℃でB8生産菌を培養し、得られた培暫液から一
般的な抗生物質採取法でFBBとBSの混合物を分離採
取し、次にこの混合物から成層親和性の差などを利用し
て18日とBaft分離し精製してFBBを得る。また
、培誉液からFBBを分離採取する際、任意の段階でF
BSをその塩に変えこのFBSの堪順を得ることもでき
る。また、FBSあるいはその塩類の利用にあたっては
Beめるいはその塩類との混合物の状態で利用すること
もでき、両者の分離は必ずしも必要ではない場合もある
PBS is produced by culturing BS-producing bacteria in the presence of fluorocytoclone according to the usual method of culturing Streptomyces, first separating and collecting a mixture of FBB and Be from the culture, and then separating FBB and BStl from the mixture. obtained by For example, for about 20 minutes under shaking or aeration in a culture solution containing carbon sources, nitrogen sources, inorganic salts, organic microorganisms, etc. used for culturing fluorocytosine and normal actinocytosine.
B8-producing bacteria are cultured at ~40°C, and a mixture of FBB and BS is separated and collected from the resulting culture medium using a general antibiotic collection method, and then a mixture of FBB and BS is collected using the difference in stratification affinity. After 18 days, Baft separation and purification are performed to obtain FBB. In addition, when separating and collecting FBB from the culture solution, FBB can be used at any stage.
You can also obtain this FBS tolerance by changing BS to its salt. Furthermore, FBS or its salts can be used in the form of a mixture with Be or its salts, and separation of the two may not necessarily be necessary.

本発明のFBB (モノ酢11ν嵐型)は以下の性質を
有する。
The FBB (monovinegar 11ν Arashi type) of the present invention has the following properties.

(1)融点 215〜220゜ (2)分子式: O+e N21 N110S F’(
3)元素分析値: Q HN O 理論値(@ 4 a y 1 6.24 25.92 
17.o a実測@(釣 4a52 6.50 23.
43 1ス21(41U Vスペクトル: aI NHOI中λmax 282.5 nm (t 
8020 )aI NaQH中λmax 275 nm
 (+15500 )1.5) ”B−NMRスペクト
ル(D20中):a +95(m、 2H)、2.5 
b〜2.65 (In、 2 H)、五47(m、2B
)、i49(m、1)1)、4.12(d、IH,J−
9Hz)、4.78(d、IH,J−9H2)、5.8
7(d、1)1.J−10HE)、6.13(d、IH
,J−1014g)、6.47(broad e、1H
)、 Z77 (d、1H,JH−p −6ag) 以下、本発明を実施例により具体的に説明するが、本発
明けこれら実施例に限定されるものではない。
(1) Melting point 215-220° (2) Molecular formula: O+e N21 N110S F'(
3) Elemental analysis value: Q HN O theoretical value (@ 4 a y 1 6.24 25.92
17. o a actual measurement @ (fishing 4a52 6.50 23.
43 1st 21 (41U V spectrum: aI NHOI λmax 282.5 nm (t
8020) aI NaQH λmax 275 nm
(+15500) 1.5) "B-NMR spectrum (in D20): a +95 (m, 2H), 2.5
b~2.65 (In, 2H), 547 (m, 2B
), i49 (m, 1) 1), 4.12 (d, IH, J-
9Hz), 4.78 (d, IH, J-9H2), 5.8
7(d,1)1. J-10HE), 6.13(d, IH
, J-1014g), 6.47 (broad e, 1H
), Z77 (d, 1H, JH-p-6ag) Hereinafter, the present invention will be explained in detail with reference to Examples, but the present invention is not limited to these Examples.

実施例 〔培養方法〕 下記要人斜面培地で生育させたStr@ptomycθ
θgriseochromogenes (KOOB−
0039) を用い、これを下記培地凰15−を含む試
験管に白金耳で接し27℃で2日間振盪培養した。次に
、下記培地lIを100−含む50〇−容の三角フラス
コに上記前培養液を2−接種し、27℃で回転培4#を
行い、1らに、FBSの前駆物質でめる5−フルオロシ
トクン(以下FOという)の5岬15−醪液を培′4#
フラスコ1本当シ、1回に3−づつ、培養後24時間、
65時間および48時間にそれぞれ添加した。
Example [Culture method] Str@ptomycθ grown in the following VIP slant culture medium
θgriseochromogenes (KOOB-
0039) was placed in a test tube containing the following medium 15- with a platinum loop and cultured with shaking at 27°C for 2 days. Next, 2 volumes of the above preculture solution were inoculated into a 500 volume Erlenmeyer flask containing 100 volumes of the following medium lI, and 4 # of rotary cultures were carried out at 27°C. -Cultivate the 5-cape 15-milk of fluorocytocone (hereinafter referred to as FO)'4#
1 flask, 3 at a time, 24 hours after incubation,
They were added at 65 hours and 48 hours, respectively.

寒天培地(Bennett’s @地)酵母エキス1(
f/を以下同様ン、肉エキス1、ペグトン2、グルコー
ス10:pH7,lJ培J11J I コーンステイープリカー10 (f/を以下同様)、可
溶性デンプン10、肉エキス10゜ペプトン10:pl
(lO 培地■ 体) ショ糖100 (V / 950 ml以下回様
)、グルコース5、(NH4)2HPO410、KOI
 、3、M gB 04・7H202、クエン酸アンモ
ニウム5 、FeSO4−7H20Q、 04、ZnS
O4・7 H2O0,04 (13) 0aO12・2H205(f / b Om
l )(4)および(B)をそれぞれ的、圧滅閉後合せ
てpH7,0に調整。
Agar medium (Bennett's @ ground) Yeast extract 1 (
f/ as below, meat extract 1, pegtone 2, glucose 10: pH 7, lJ culture J11J I cornstarch liquor 10 (f/ as below), soluble starch 10, meat extract 10゜peptone 10: pl
(lO medium ■ body) Sucrose 100 (V / 950 ml or less), Glucose 5, (NH4)2HPO410, KOI
, 3, M gB 04・7H202, ammonium citrate 5, FeSO4-7H20Q, 04, ZnS
O4・7 H2O0,04 (13) 0aO12・2H205(f/b Om
1) (4) and (B) were each combined and adjusted to pH 7.0 after crushing.

FC添加培養で生産されるFBBを定晰するために、培
養液のサンプルより後述の方法でpcを除去した後Ba
cillus cerθus IAM−1729に対す
る阻害活性を調べた。このサンプルにはIF B 8と
BSが含壕れているので、別にBE3単独の1イi全油
性を自べて標@@を作成し、これとサンプルのtill
害活性全活性して1PBBの定情分行った。
In order to clarify the FBB produced in FC-added culture, after removing PC from the culture solution sample using the method described below, Ba
The inhibitory activity against cillus cerθus IAM-1729 was investigated. This sample contains IF B 8 and BS, so I separately created a standard @@ for the 1i total oiliness of BE3 alone, and compared this and the sample's till.
A total of 1 PBB of harmful activity was activated.

その結果、培養72時間で弱い活性か現われ、144時
間後から急激に活性が上昇し、192時間で最大の活性
が認められた。
As a result, a weak activity appeared after 72 hours of culture, the activity rapidly increased after 144 hours, and the maximum activity was observed at 192 hours.

〔精製J 培養液f 3 N −NaOHでpH8に調整後濾過し
、培養戸液を得、これをダイヤイオンBP20に吸着さ
せた。ダイヤイオン1(P20吸着画分をa I N 
−HOI性60係ア七トンで溶出して濃縮し、アセトン
除去後、カラムクロマトグラフィー(アンバーライトエ
RA 410 (OH−) )を通過させ、さらにカラ
ムクロマトグラフィー(ダウエックス50WX2(H+
))に吸着させた。I&着画分をまず5%ピリミジンで
洗浄して着色した夾雑物を除き、次いで1.2%NH4
01(で溶出した。
[Purification J Culture solution f 3 After adjusting the pH to 8 with NaOH, the solution was filtered to obtain a culture solution, which was adsorbed onto Diaion BP20. Diaion 1 (P20 adsorption fraction a I N
- After eluting with HOI 60 acetate and concentrating, removing acetone, passing through column chromatography (Amberlite RA 410 (OH-)), and further column chromatography (Dowex 50WX2 (H+
)). The I & colored fraction was first washed with 5% pyrimidine to remove colored impurities, and then washed with 1.2% NH4.
01 (eluted.

1tE、OH溶出画分はFBEIおよびBSの混合物で
あり、これらの分+7!iitダウエックス50w×8
を用いたレジンクロマトグラフィーにより行った。2X
20c+++のカラムを用い、展開溶媒として[15M
ピリミジン「有酢+*、 4? 1肋液(pH4、7)
 i使用し、溶出画分を前i1i: B、 cereu
sの阻害活性で棚べた。その結果、活++画分は700
〜1200−と1600〜2700−の2つに分れ、前
者がFBSであった。次に前者をブタノール二酢酸:水
=2:1:1の展開溶媒を用いたベーパークロマトグラ
フィーの切り取り法にょルjFfI製し、精製FBSを
得た。培養液1tから得られたFBSは50叩であった
The 1tE,OH elution fraction is a mixture of FBEI and BS, and these fractions +7! iit dowex 50w x 8
This was done by resin chromatography using . 2X
Using a column of 20c+++, [15M
Pyrimidine "Vinegar + *, 4? 1 costal fluid (pH 4, 7)
Use i and pre-eluted fractions: B, cereu
The inhibitory activity of S. As a result, the active ++ fraction was 700
It was divided into two, ~1200- and 1600-2700-, and the former was FBS. Next, the former was purified by vapor chromatography using a developing solvent of butanol diacetic acid:water = 2:1:1 to obtain purified FBS. The FBS obtained from 1 ton of culture solution was 50 kg.

Claims (1)

【特許請求の範囲】 1、 下記式口]で表わされるフにオロブラストサイジ
ン8あるいはその塩類。 2 フルオロクトゾン存在下にプラストサイジン日生産
藺を培養し、その培養物から下記式[Dで表わされるフ
ルオロプラストサイジンSろるいはその塩類を採取する
ことを%倣とするフルオロプラストサイジンSあるいは
その塩類の製法。
[Scope of Claims] 1. Fluoroblasticidin 8 or its salts represented by the following formula. 2. Cultivating plasticidin strawberries in the presence of fluoroctozone, and collecting fluoroplasticidin S or its salts represented by the following formula [D] from the culture. Manufacturing method for Gin S or its salts.
JP58231248A 1983-12-09 1983-12-09 Fluoroblasticidin s and its preparation Pending JPS60123486A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58231248A JPS60123486A (en) 1983-12-09 1983-12-09 Fluoroblasticidin s and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58231248A JPS60123486A (en) 1983-12-09 1983-12-09 Fluoroblasticidin s and its preparation

Publications (1)

Publication Number Publication Date
JPS60123486A true JPS60123486A (en) 1985-07-02

Family

ID=16920641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58231248A Pending JPS60123486A (en) 1983-12-09 1983-12-09 Fluoroblasticidin s and its preparation

Country Status (1)

Country Link
JP (1) JPS60123486A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011017545A1 (en) 2009-08-07 2011-02-10 Dow Agrosciences Llc N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
US9840475B2 (en) 2012-12-28 2017-12-12 Adama Makhteshim Ltd. N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1(2H)-carboxamide derivatives
US9908855B2 (en) 2012-12-28 2018-03-06 Adama Makhteshim Ltd. N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1(2H)-carboxylate derivatives
US10059703B2 (en) 2012-12-31 2018-08-28 Adama Makhteshim Ltd. 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1H)-one derivatives as fungicides

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011017545A1 (en) 2009-08-07 2011-02-10 Dow Agrosciences Llc N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
EP2461686A1 (en) * 2009-08-07 2012-06-13 Dow AgroSciences LLC N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
EP2461686A4 (en) * 2009-08-07 2013-02-13 Dow Agrosciences Llc N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
US9000002B2 (en) 2009-08-07 2015-04-07 Dow Agrosciences Llc N1-substituted-5-fluoro-2-oxopyrimidinone-1(2H)-carboxamide derivatives
US9840475B2 (en) 2012-12-28 2017-12-12 Adama Makhteshim Ltd. N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1(2H)-carboxamide derivatives
US9908855B2 (en) 2012-12-28 2018-03-06 Adama Makhteshim Ltd. N-(substituted)-5-fluoro-4-imino-3-methyl-2-oxo-3,4-dihydropyrimidine-1(2H)-carboxylate derivatives
US10059703B2 (en) 2012-12-31 2018-08-28 Adama Makhteshim Ltd. 3-alkyl-5-fluoro-4-substituted-imino-3,4-dihydropyrimidin-2(1H)-one derivatives as fungicides

Similar Documents

Publication Publication Date Title
DE2560074C2 (en) Process for the production of clavulanic acid and its salts
DE1803987A1 (en) New, physiologically active peptidolipid and process for its production
CH638241A5 (en) ENZYMPRAEPARAT WITH L-ALPHA-AMINOACYLAMIDASE ACTIVITY.
EP0599159B1 (en) Heterogeneous protein mixture with alpha-L-rhamnosidase activity, process for preparation and use.
DE3012565C2 (en)
JPS60123486A (en) Fluoroblasticidin s and its preparation
DE2723463C3 (en) Process for the preparation of 7-aminocephem compounds
DE2537028A1 (en) ANTIBIOTICUM, A METHOD FOR ITS MANUFACTURING AND ITS USE AS A PLANT PROTECTION PRODUCT
DE1620639A1 (en) Process for the preparation of 9-ss-D-ribofuranosyl-7-deazapurine-3 ', 5'-cyclophosphates
DE2445581C3 (en) Process for the preparation of D-gluconic acid-dlactam
DE3048421C2 (en) Antibiotic substance, process for its manufacture and antifungal agent containing it
US3975235A (en) Process for the production of cephamycin type antibiotic substances
DE2054310C3 (en) Process for the preparation of (-) - (cis-1 ^ -EpoxypropyO-phosphonic acid
US4430431A (en) Producing fusafungine
EP0167954A2 (en) 1-Hydroxy-cytorhodines, a microbiological method for their preparation and their use as cytostatic agents
JPS589676B2 (en) Nojirimycin B
US3555075A (en) Novel antifungal agents
DE2645548A1 (en) ENDONUCLEASEN AND METHOD OF MANUFACTURING IT
DE2448343C3 (en) Deoxyribonuclease and its use for the production of deoxyribonucleotides with terminal deoxyguanosine
DE2610557A1 (en) NEW NAPHTHACEN DERIVATIVE, ITS MANUFACTURING AND COMPOSITIONS CONTAINING IT
DE2905066C2 (en) Antibiotic SF-2050B, method of making the same, and antibacterial agents containing the same
JPH06141856A (en) Production of cycloinulooligosaccharide and enzyme capable of producing the same
JPS60199849A (en) Phenalen-1-one derivative
JPH04197191A (en) Compound ms-347
JPS6221354B2 (en)